In producing lissodendoric acid A, the team used a method they say may help accelerate the process of drug discovery
A therapeutic sponge the size of a pencil eraser boosted the body’s tumor-fighting response in mice and kept the cancer from returning
The study demonstrates a need for more patient-centered care during hospitalization.
Manufacturers, through a loophole in the law, can use unsafe medical devices as a basis for bringing new, related products to market.
Yale researchers have identified a potential target for the development of antihypertensive drugs.
While COVID-19 boosters have been found to protect against infection, hospitalization, and severe illness, the waning of their protection has led to uncertainty about when it is most appropriate to get an additional booster shot.
A programme to increase the use of magnesium sulfate, a £1 injection that helps prevent cerebral palsy in premature babies, is effective according to a National Institute for Health and Care Research (NIHR) funded evaluation.
Researchers from North Carolina State University identified and addressed a flaw in a commonly used pandemic model that can cause the model to severely underestimate disease spread.
In Hawaiʻi, Native Hawaiian cancer patients have a two-fold increased risk of dying from sepsis, a life-threatening immune response to an infection, compared to other ethnicities, according to a new study co-authored by University of Hawaiʻi Cancer Center researchers.
A study led by a North Carolina State University researcher found that although there were steep learning losses in reading for elementary school students during the COVID-19 pandemic,
A team of researchers led by North Carolina State University compared wastewater monitoring and two other COVID-19 surveillance approaches in Raleigh, N.C., during the start of the pandemic.
Child deaths in England increased during 2021 to 2022 and have returned close to pre-pandemic levels, according to a new study, led by researchers from the University of Bristol’s National Child Mortality Database (NCMD) team and published in JAMA Network Open today [9 January].
The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms, according to a study led by researchers at Weill Cornell Medicine.
UC San Diego study reveals critical insights into the complex biology of tissue-specific T cells, paving the way for a new branch of precision therapeutics.
An experimental dementia drug slowed clinical decline in people with early-stage Alzheimer’s disease in a phase 3 clinical trial, a new study shows.
A new Yale-led study finds that testing for a single immune system molecule on nasal swabs can help detect stealthy viruses not identified in standard tests.
A new analysis of how far Americans have to travel to receive COVID-19 oral treatments like Paxlovid reveals stubborn discrepancies in health care access.
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients.
Nearly three years into the pandemic, many of us now carry antibodies against the virus—due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment.
Like the New York City subway system, the DNA in our cells needs to operate around the clock—and it’s in constant need of repair.